Hope Medicine announces HMI-115 phase II clinical trial for androgenetic alopecia in China
    Research/Science 3/19/2023

    Hope Medicine's announcement of the HMI-115 Phase II clinical trial for androgenetic alopecia in China; other related trials have been conducted or are ongoing in different countries, including Australia, US, and Europe. There is speculation that the product may be accepted across borders without additional testing.
    View this post in the Community →

    Similar Community Posts Join

    5 / 140 results

    Related Research

    6 / 45 results